We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I was just reading Badstermans post on Sunday... referencing Sareum's Dr Michael Owen (Non Exec Director) co-founded Kymab. Their monoclonal antibody was purchased by Sanofi for 1.1 BILLION plus 350,000 milestone payments.
With a multitude of game changers in development we only need one of these to come home and the SP is stepping up beyond any of my original expectations.
WIP a nice change from the vaccine rant ... I think our BB has been hijacked somewhat ... We are NOT a vaccine company ... FGS
Bit of Tyk2 reading for you too
https://www.edisongroup.com/publication/treading-the-tyk2-trail/29435/
Just sell the shares you may or may or may not own
Or do the simple research that will explain why we are all invested and what you should have done before investing simples
Hi all.
Just watched this.
The last 30 minutes may give an better understanding of what we do.
GLA
Extra Life: A Short History of Living Longer
Series 1: 2. Medical Drugs
https://www.bbc.co.uk/iplayer/episode/m000wfbw/extra-life-a-short-history-of-living-longer-series-1-2-medical-drugs
Greeno, something to whet your appetite (assuming the science is tough reading).
Sareum's Dr Michael Owen (Non Exec Director) co-founded Kymab. Their monoclonal antibody was purchased by Sanofi for 1.1 BILLION plus 350,000 milestone payments.
http://www.sareum.com/about-us/management/
Then have a look at Sareum's pipeline, the patents and the multiple indications that can be treated. After that get your calculator out and do some maths.
I would suggest £1 a share is not an unreasonable target.
I didn't read Anti's post before posting. Looks like we think alike.
Green. You're in luck, this is the best BB around for info. The regular poster's here are the best researched of all the boards I've visited.
Come on - asking the board to do your due diligence, idleness of the highest order
Hi Green. There has been a bit of consternation here recently.
If you have a bit of time on your hands I would personally, aka, my opinion look up cytokine storms. Causation and treatment. Cytosine and tyrosine (now called thymine) displaced with uracil are a starter.
And sareums ipr.
I am reticent to make my opinion here public re our potential for what I believe is the real deal.
But time will tell. Indicators are supportive.
Well done green .. I suggest you do a bit of reading before you invest ... You may well come to the conclusion that it's a worthy investment ... ATB Mafuta
Thanks danny for the information, I have just come across Sareum as an investment opportunity.
Green - How many employees do you think Sareum should have?
I hope you have read everything on the Sareum website as later on there will be a quiz.
Do not invest in any business that you don't understand.
How we work
Sareum operates a lean business model to deliver the most productive return for our research spend. This is accomplished by:
maintaining a low cost base by having a small in-house teamundertaking laboratory-based research using external providersengaging in research and development collaborations to share costs and access expertisehaving access to a worldwide network of expert research providers to progress programmespursuing multiple drug development programmes to reduce the risk to the company
The goals are to build value by progressing our research programmes through early clinical development and generate revenues by licensing them to pharmaceutical company partners.
Find out more about our partners and current collaborations.
Green. Hope that assists you on your query just before trading update on Monday and improved 1802 grant the day after...and submarine patent...so why your point re number of employees?
A board of conductors utilise various musicians to make a harmony sing.
Get it yet?
Green .. what TRAIL are they walking? ... Are you on the right chat board?? ... Try rambling.com
Green. You might do well to look at Sareums website. And then read the RNSs going back to 2010.
batonrouge what has pub got to do with Sareum
just looking for information, if you don't know say so
Green, why don't you go down the pub.
Thanks HBD for the link, but does company really only have 6 employees ?
Hard to believe company with 6 employees and doing all these trails.
Exactly HBD. And the 'How we work' tab is relevant.
When doing your own research, begin here http://www.sareum.com/about-us/what-we-do/
Can someone explain in plain English what does Sareum Holdings do ?
I see there are only 6 employees in the company, up to 2019 there were only two employees.
It a fund manager investing in new medicine
How many development it has in phase I, II or III
What other trials Sareum involved in!